Molecular docking study of lignanamides from Cannabis sativa against P-glycoprotein.
Ontology highlight
ABSTRACT: P-glycoprotein (P-gp), which was first identified in cancer cells, is an ATP-dependent efflux transporter that expels a wide variety of cytotoxic compounds out of cells. This transporter can decrease the bioavailability of therapeutic drugs by preventing their sufficient intracellular accumulation. Over expression of P-gp in cancer cells lead to multidrug resistance (MDR) phenotype that is one of the main reasons for the failure of chemotherapy. Hence, P-gp inhibition is a favorable method to reverse MDR. In this study, the lignanamides from Cannabis sativa were docked against P-gp to recognize potential binding affinities of these phytochemicals. Tariquidar and zosuquidar, two well-known P-gp inhibitors, were selected as the control ligands. It was observed that cannabisin M and ca
SUBMITTER: Kazemi F
PROVIDER: S-EPMC7779379 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA